Catalyst Wire Dossier Catalyst Wire Dossier

Meningococcal conjugate vaccine (MenACWY-CRM197)

Meningococcal conjugate vaccine · Novartis Vaccines
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Meningococcal conjugate vaccine (MenACWY-CRM197), covering 2013-11-20 to 2013-11-20. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Safety and Immune Response of a Meningococcal Conjugate Vaccine Administered to Healthy Adolescents [Phase 2]

See pricing